274 related articles for article (PubMed ID: 31502023)
1. The Prognostic Value of Lymphovascular Invasion in Truncal and Extremity Soft Tissue Sarcomas: An Analysis from the National Cancer Database.
Ethun CG; Lopez-Aguiar AG; Switchenko JM; Gillespie TW; Delman KA; Staley CA; Maithel SK; Cardona K
Ann Surg Oncol; 2019 Dec; 26(13):4723-4729. PubMed ID: 31502023
[TBL] [Abstract][Full Text] [Related]
2. Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative.
Zaidi MY; Ethun CG; Tran TB; Poultsides G; Grignol VP; Howard JH; Bedi M; Mogal H; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick B; Fields RC; Oskouei S; Reimer N; Monson D; Maithel SK; Cardona K
Ann Surg Oncol; 2019 Oct; 26(11):3542-3549. PubMed ID: 31342400
[TBL] [Abstract][Full Text] [Related]
3. The Oncologic Impact of Postoperative Complications Following Resection of Truncal and Extremity Soft Tissue Sarcomas.
Broecker JS; Ethun CG; Monson DK; Lopez-Aguiar AG; Le N; McInnis M; Godette K; Reimer NB; Oskouei SV; Delman KA; Staley CA; Maithel SK; Cardona K
Ann Surg Oncol; 2017 Nov; 24(12):3574-3586. PubMed ID: 28895084
[TBL] [Abstract][Full Text] [Related]
4. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
[TBL] [Abstract][Full Text] [Related]
5. High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival (RFS) After Resection of Extremity and Truncal Soft Tissue Sarcoma.
Traweek RS; Lyu HG; Witt RG; Snyder RA; Nassif EF; Krijgh DD; Smith JM; Tilney GS; Feng C; Chiang YJ; Torres KE; Roubaud MJ; Scally CP; Hunt KK; Keung EZ; Mericli AF; Roland CL
Ann Surg Oncol; 2024 Jun; 31(6):4138-4147. PubMed ID: 38396039
[TBL] [Abstract][Full Text] [Related]
6. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.
Pasquali S; Pizzamiglio S; Touati N; Litiere S; Marreaud S; Kasper B; Gelderblom H; Stacchiotti S; Judson I; Dei Tos AP; Verderio P; Casali PG; Woll PJ; Gronchi A;
Eur J Cancer; 2019 Mar; 109():51-60. PubMed ID: 30690293
[TBL] [Abstract][Full Text] [Related]
7. The impact of unplanned excisions of truncal/extremity soft tissue sarcomas: A multi-institutional propensity score analysis from the US Sarcoma Collaborative.
Zaidi MY; Ethun CG; Liu Y; Poultsides G; Howard JH; Mogal H; Tseng J; Votanopoulos K; Fields RC; Cardona K
J Surg Oncol; 2019 Sep; 120(3):332-339. PubMed ID: 31172536
[TBL] [Abstract][Full Text] [Related]
8. Comparison of outcome and toxicity of postoperative intensity-modulated radiation therapy with two-dimensional radiotherapy in patients with soft tissue sarcoma of extremities and trunk.
Wang J; Song Y; Liu X; Jin J; Wang W; Yu Z; Liu Y; Li N; Fang H; Ren H; Tang Y; Tang Y; Chen B; Lu N; Qi S; Wang S; Li Y
Cancer Med; 2019 Mar; 8(3):902-909. PubMed ID: 30740916
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the 7th and 8th version of the AJCC classification system for soft tissue sarcomas of extremities and trunk in patients with localised, intermediate or high-grade disease treated at European tertiary sarcoma centres.
Smolle MA; van de Sande M; Hayes A; Bergovec M; Smith HG; Liegl-Atzwanger B; Tunn PU; Niethard M; Windhager R; Szkandera J; Leithner A
Eur J Surg Oncol; 2021 Aug; 47(8):2182-2188. PubMed ID: 33865657
[TBL] [Abstract][Full Text] [Related]
10. Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer.
Wang S; Zhang B; Qian J; Qiao R; Xu J; Zhang L; Zhao Y; Zhang Y; Wang R; Zhao R; Han B
Lung Cancer; 2018 Nov; 125():245-252. PubMed ID: 30429028
[TBL] [Abstract][Full Text] [Related]
11. Comparative Performance of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Systems for Soft Tissue Sarcoma of the Trunk and Extremities.
Fisher SB; Chiang YJ; Feig BW; Cormier JN; Hunt KK; Torres KE; Roland CL
Ann Surg Oncol; 2018 May; 25(5):1126-1132. PubMed ID: 29468609
[TBL] [Abstract][Full Text] [Related]
12. A closer look at the natural history and recurrence patterns of high-grade truncal/extremity leiomyosarcomas: A multi-institutional analysis from the US Sarcoma Collaborative.
Lee RM; Ethun CG; Zaidi MY; Tran TB; Poultsides GA; Grignol VP; Howard JH; Bedi M; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Oskouei SV; Monson DK; Reimer NB; Maithel SK; Cardona K
Surg Oncol; 2020 Sep; 34():292-297. PubMed ID: 32891345
[TBL] [Abstract][Full Text] [Related]
13. Follow-up after initial surgical treatment of soft tissue sarcomas in the extremities and trunk wall.
Hovgaard TB; Nymark T; Skov O; Petersen MM
Acta Oncol; 2017 Jul; 56(7):1004-1012. PubMed ID: 28287011
[TBL] [Abstract][Full Text] [Related]
14. Lymphovascular invasion can be better than pathologic complete response to predict prognosis in breast cancer treated with neoadjuvant chemotherapy.
Ryu YJ; Kang SJ; Cho JS; Yoon JH; Park MH
Medicine (Baltimore); 2018 Jul; 97(30):e11647. PubMed ID: 30045313
[TBL] [Abstract][Full Text] [Related]
15. A Novel T-Stage Classification System for Adrenocortical Carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group.
Poorman CE; Ethun CG; Postlewait LM; Tran TB; Prescott JD; Pawlik TM; Wang TS; Glenn J; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solórzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Staley CA; Poultsides GA; Maithel SK
Ann Surg Oncol; 2018 Feb; 25(2):520-527. PubMed ID: 29164414
[TBL] [Abstract][Full Text] [Related]
16. A novel, simplified, externally validated staging system for truncal/extremity soft tissue sarcomas: An analysis of the US Sarcoma Collaborative database.
Johnson AC; Ethun CG; Liu Y; Poultsides G; Howard JH; Bedi M; Charlson J; Tseng J; Roggin KK; Votanopoulos K; Cullinan D; Fields RC; Maithel SK; Cardona K;
J Surg Oncol; 2018 Dec; 118(7):1135-1141. PubMed ID: 30261111
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma.
Li B; Xiong XZ; Zhou Y; Wu SJ; You Z; Lu J; Cheng NS
World J Gastroenterol; 2017 Sep; 23(36):6685-6693. PubMed ID: 29085213
[TBL] [Abstract][Full Text] [Related]
18. Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcoma.
Yu PY; Beal EW; Hughes TM; Suarez-Kelly LP; Shelby RD; Ethun CG; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
J Surg Res; 2018 Nov; 231():248-256. PubMed ID: 30278937
[TBL] [Abstract][Full Text] [Related]
19. Soft Tissue Sarcomas of the Extremities: Surgical Margins Can Be Close as Long as the Resected Tumor Has No Ink on It.
Harati K; Goertz O; Pieper A; Daigeler A; Joneidi-Jafari H; Niggemann H; Stricker I; Lehnhardt M
Oncologist; 2017 Nov; 22(11):1400-1410. PubMed ID: 28739867
[TBL] [Abstract][Full Text] [Related]
20. Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter study.
Bonvalot S; Wunder J; Gronchi A; Broto JM; Turcotte R; Rastrelli M; Papai Z; Radaelli S; Lindner LH; Shumelinsky F; Cubillo A; Rutkowski P; Demaire C; Strens D; Nalbantov G
Eur J Surg Oncol; 2021 Aug; 47(8):2166-2172. PubMed ID: 33676792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
